Back
Beam Therapeutics Vs. Editas Medicine Industry Stock Comparison
Sell
45
BEAM
Beam Therapeutics
Last Price:
24.83
Seasonality Move:
29.02%
Sell
49
EDIT
Editas Medicine
Last Price:
5.52
Seasonality Move:
18.83%
Sell
45
Beam Therapeutics (BEAM)
is a Sell
Is Beam Therapeutics a Buy, Sell or Hold?
- The current Beam Therapeutics [BEAM] share price is $24.62. The Score for BEAM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
- The current Editas Medicine [EDIT] share price is $5.62. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BEAM Stock Price Chart
What is Beam Therapeutics's stock price today?
-
The Beam Therapeutics share price today is $24.62
The current trend is relatively stagnant and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $5.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
BEAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.89 | Sell |
Relative Strength Index (14 RSI): | 50.97 | Buy |
Chaikin Money Flow: | 820935 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.93 - 24.45) | Buy |
Bollinger Bands (100): | (23.39 - 34.29) | Sell |
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 45.45 | Sell |
Chaikin Money Flow: | -1391038 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.32 - 5.8) | Buy |
Bollinger Bands (100): | (6.04 - 9.06) | Sell |
BEAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.3 | Buy |
20-day SMA: | 22.79 | Buy |
50-day SMA: | 27.84 | Sell |
200-day SMA: | 26.69 | Sell |
8-day EMA: | 23.6 | Buy |
20-day EMA: | 23.81 | Buy |
50-day EMA: | 26.24 | Sell |
200-day EMA: | 28.87 | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.6 | Buy |
20-day SMA: | 5.52 | Buy |
50-day SMA: | 6.53 | Sell |
200-day SMA: | 8.08 | Sell |
8-day EMA: | 5.68 | Sell |
20-day EMA: | 5.73 | Sell |
50-day EMA: | 6.39 | Sell |
200-day EMA: | 7.99 | Sell |
Beam Therapeutics Earnings Growth & BEAM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.51 per share, and an increase next year of $0.00 per share.
Editas Medicine Earnings Growth & EDIT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.41 per share, and an increase next year of $0.04 per share.
Beam Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Editas Medicine Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |